ICT Ep23: Q3 Results with Joel White (Part 2)
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
ICT Ep23: Q3 Results with Joel White (Part 2)
-
ナレーター：
-
著者：
このコンテンツについて
Innovating Clinical Trials Podcast Series: Part 2 - Pricing Strategies and Emerging Dynamics
Welcome to Innovating Clinical Trials podcast, where we continue to explore the rapidly evolving landscape of clinical research. In part 2, hosts Liam Eves and Ted Trafford are joined once again by industry analyst Joel White to dive into the complexities of pricing strategies and the shifting dynamics in the CRO and biotech sectors.
This episode unpacks the implications of pricing pressures, the role of FSP models, and the increasing consolidation of site networks. Joel shares his expert insights into how these trends are shaping the industry and what they mean for sponsors, CROs, and site organizations alike. Whether you’re managing trials, building partnerships, or navigating competitive pricing environments, this episode is packed with thought-provoking takeaways.